Arbor Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Arbor Pharmaceuticals

Access the complete profile.

Arbor Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	423 Merchant Wholesalers, Durable Goods
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	6 Concourse Pkwy Ste 1800 Atlanta, GA 30328

Note: Revenues for privately held companies are statistical evaluations.


Arbor Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Arbor Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Arbor Pharmaceuticals is classified as operating in the Merchant Wholesalers, Durable Goods industry, NAICS Code 423.

Arbor Pharmaceuticals Annual Revenue and Growth Rate

Arbor Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Arbor Pharmaceuticals's revenues are gauged from an analysis of company filings.

Arbor Pharmaceuticals's Income Statement (based on Industry Averages)

Arbor Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Arbor Pharmaceuticals is developing and marketing. Arbor Pharmaceuticals doesn't have any recent trademark applications, indicating Arbor Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
THYNATURI Pharmaceutical preparations for the treatment of hypothyroidism	10/01/2021
ADTHYZA Pharmaceutical preparations for the treatment of hypothyroidism	10/01/2021
EVEKEO ODT Pharmaceutical preparations for the treatment of ADHD, narcolepsy and obesity	01/13/2020

See all trademarks and details in the Full Report.

Market Share of Arbor Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Arbor Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PGW AUTO GLASS	Cranberry, PA	100
TOYOTA MOTOR NORTH AMERICA	Plano, TX	57
GENUINE PARTS	Atlanta, GA	39
BUILDERS FIRSTSOURCE	Dallas, TX	30
THERMO FISHER SCIENTIFIC	Pittsburgh, PA	25
DEALER TIRE	Cleveland, OH	21
ROBERT BOSCH	Farmington Hills, MI	19
FERGUSON ENTERPRISES	Newport News, VA	18
ARROW ELECTRONICS	Centennial, CO	14

Nearby Competitors

These companies are similar in business line and location to Arbor Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GENUINE PARTS	Atlanta, GA	100
MERCEDES-BENZ USA	Sandy Springs, GA	10
TIREHUB	Dunwoody, GA	6
PORSCHE BUSINESS SERVICES	Atlanta, GA	3
SAFE-GUARD PRODUCTS INTERNATIONAL	Atlanta, GA	2
PRECISION AVIATION GROUP	Atlanta, GA	1

Future Competition: Arbor Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Arbor Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)